Mednet Logo

When do you consider switching from another biologic to benralizumab in patients with severe eosinophilic asthma with a history of suboptimal response to previous biologic agents?

Do the findings from PMID 38575162 influence your approach?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Pulmonology · Ohio State University Wexner Medical Center
Answered on

Hi - I would consider after a few months. I personally have had considerable success with benralizumab in patients with severe eosinophilic asthma and it is generally my first line agent.

Join for free or sign in to see the full answer